Background: Inherited risk of pancreatic cancer has been associated with mutations in several genes, including BRCA2, CDKN2A (p16), PRSS1, and PALB2. We hypothesized that common variants in these genes, single nucleotide polymorphisms (SNP), may also influence risk for pancreatic cancer development. Methods: A clinic-based case-control study in nonHispanic white persons compared 1,143 patients with pancreatic adenocarcinoma with 1,097 healthy controls. Twenty-eight genes directly and indirectly involved in the Fanconi/BRCA pathway (includes BRCA1, BRCA2, and PALB2) were identified and 248 tag SNPs were selected. In addition, 11 SNPs in CDKN2A, PRSS1, and PRSS2 were selected. Association studies were done at the gene level by principal components analysis, whereas recursive partitioning analysis was used to investi-
Introduction
The double-stranded break repair pathway is a unique pathway of response to DNA cross-linking and subsequent repair; the exact mechanism of which is as yet undetermined (1) . High-penetrance mutations in doublestranded break repair genes such as BRCA1 and BRCA2 increase susceptibility to cancer, most notably breast and ovarian cancers (2, 3) , but also have been reported in familial pancreatic cancer kindreds (4) (5) (6) . Truncating mutations in FANCC and FANCG have been reported in a few cases of sporadic young-onset pancreatic cancer, although their contribution to pancreatic cancer risk is unclear (7) (8) (9) , whereas truncating mutations in PALB2 have also recently been documented in familial pancreatic cancer kindreds (10) . Other genes involved in hereditary susceptibility to pancreatic cancer include CDKN2A (familial melanoma) and PRSS1 (hereditary pancreatitis).
We hypothesized that low-penetrance polymorphisms could confer a modest increase in risk for pancreatic cancer. Unlike highly penetrant truncating mutations or large deletions, these polymorphic variants may be associated with alterations in gene function or expression to a more limited extent.
Materials and Methods
Written informed consent was obtained from each subject for participation in this study and provision of biospecimens. This study was approved by the Mayo Clinic Institutional Review Board.
Cases. From October 2000 to March 2007, patients with clinically documented pancreatic adenocarcinoma were recruited to a prospective registry during their visit to Mayo Clinic (Rochester, Minnesota or Jacksonville, Florida), as previously described (11).
Controls.
From May 2004 to February 2007, healthy controls were recruited from the General Internal Medicine clinics at Mayo Clinic (Rochester). Controls were frequency matched to cases on sex, location of residence, age at time of recruitment (in 5-y increments), and race/ ethnicity, as previously described (11) .
Single Nucleotide Polymorphism Selection. A linkage disequilibrium-based tag single nucleotide polymorphism (SNP) strategy was used (12) . Known genes directly and indirectly involved in double-stranded break repair were identified (n = 28; Genotyping. DNA samples were analyzed in the Mayo Clinic Genotyping Shared Resource using an Illumina Golden Gate Custom 768-plex OPA panel using the standard protocol. BeadStudio II software was used to analyze the data and prepare reports. DNA samples from cases and controls were randomly placed on plates.
Quality Control. Positive and negative controls were run in parallel to assess the quality of genotyping. All genotype clusters were manually inspected by a molecular geneticist (J.M.C.). Call rates were high for SNPs overall, at 99.6% rate for samples, and 95.1% for loci. Forty-seven pairs were used for duplicate concordance, with a 99.9% concordance rate. Eighteen SNPs failed to amplify and 91 samples had a call rate of 0.
Statistical Methods. Risk factor questionnaires were completed by 100% of controls and 71% of cases. For cases missing risk factor questionnaires, clinical data were extracted from available medical records, with a high intermethod reliability as previously reported (12) . Hardy-Weinberg equilibrium was confirmed in controls for each SNP by χ 2 test. Those failing were excluded from the analysis (n = 2). A principal components analysis (14) approach was used to test for an overall association between disease and the multiple SNPs genotyped within each gene. The necessary number of principal components needed for each gene was determined using a 90% explained variance criteria. Once the necessary principal components were determined, multivariable logistic regression models were constructed to assess the significance of each gene. We had 88% power to detect an odds ratio of 1.35 with a minor allele frequency of 0.10 and 90% power to detect an odds ratio of 1.25 with a minor allele frequency of 0.25.
Allele associations were assessed using the Pearson χ 2 or Fisher's exact test (when sample sizes were small), and genotype associations were assessed using the CochranArmitage trend test. Multivariate analysis compared genotype frequencies in cases and controls adjusted for age, sex, ever/never smoking status, family history of pancreatic cancer (first degree), and body mass index (BMI).
Results
Demographic characteristics of cases and controls are shown in Table 1 . There were differences in BMI, sex, percent of ever smokers, percent reporting a first-degree relative with pancreatic cancer, and diabetes. Adjusted principal components analyses for each gene (Table 2) showed no association for any gene with pancreatic cancer risk. Logistic regression analyses at the single SNP level for each gene were also done using multivariable additive, dominant, and recessive models. Statistically significant associations are shown in Supplementary Table S1 , although no associations would remain significant after Bonferroni adjustment. The proportion of positive findings (4.0-4.2% for the three models) are within the range expected by chance (α = 0.05).
Recursive partitioning analysis was done as an exploratory method to assess SNP-SNP associations within the pathway and SNP-environment interactions. No partitions by SNPs reached statistical significance in these analyses, and no interaction was identified from this analysis ( Supplementary Fig. S1 ).
Discussion
This large case-control study designed to assess common variants in genes associated with hereditary cancer or familial pancreatic cancer did not find associations of polymorphic variants with pancreatic cancer risk. Therefore, we conclude that functional variations of modest effect that might be associated with common polymorphisms in these genes do not seem to confer increased risk for pancreatic cancer. For instance, for the DNA repair genes, it is probable that only somatic loss of heterozygosity in the setting of a defective allele results in a neoplastic transformation, but minor germ-line variation in DNA repair capacity does not seem to meaningfully influence risk for pancreatic cancer. When high-throughput DNA sequencing is practically scaled to large numbers of subjects, it may be possible to identify high-penetrance mutations in key pathways that confer risk in "sporadic" pancreatic cancer patients as well as in the familial pancreatic cancer setting.
Conclusion
In a tag SNP analysis of genes associated with familial pancreatic cancer and genes associated with DNA doublestranded break repair, polymorphic variants were not associated with risk for pancreatic cancer.
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